Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Oct / £1 Paper Sensor Detects Pathogens in Wastewater in 90 Min
Analytical science Infectious Disease

£1 Paper Sensor Detects Pathogens in Wastewater in 90 Min

£1 paper microfluidic sensor can detect SARS-CoV-2 and influenza in community wastewater in under 90 minutes

By Jessica Allerton 10/18/2024 News 3 min read

Share

A paper-based microfluidic platform for the on-site detection of pathogens in wastewater can detect viruses like SARS-CoV-2 and influenza from wastewater samples, providing results in less than 1.5 hours.

The device integrates a paper microfluidic platform with loop-mediated isothermal amplification (LAMP), a highly sensitive technique for amplifying viral RNA without the need for complex thermal cycling equipment. The platform is capable of detecting viral genetic material at concentrations as low as 10 copies per milliliter, a sensitivity comparable to polymerase chain reaction (PCR) tests. Unlike PCR, however, the LAMP-based approach eliminates the need for centralized laboratories and skilled technicians, making it accessible for on-site testing in community settings.

Credit: Science Museum Group 

Copyright: Board of Trustees of the Science Museum

The “origami” microfluidic device is designed for ease of use. Wastewater samples are filtered using a simple syringe-based system, which removes impurities while concentrating the viral RNA. The samples are then subjected to the LAMP reaction on the paper device, where fluorescence indicates the presence of viral RNA. The results can be read using a mobile phone camera or a handheld UV light, enabling rapid, semi-quantitative analysis in the field.

The research team tested the device in real-world conditions by sampling wastewater from four quarantine hotels near London Heathrow Airport during the COVID-19 pandemic. Results from the paper device were compared with those from standard laboratory-based RT-qPCR assays. The paper device demonstrated high sensitivity and specificity for detecting the ORF1ab, S, and N genes of SARS-CoV-2, as well as genes associated with influenza A and B.

The field testing showed that the paper device could detect SARS-CoV-2 in community wastewater with similar accuracy to conventional RT-qPCR methods – without the logistical challenges of transporting samples to distant laboratories.

The researchers highlighted the potential of the paper device for future pandemic preparedness, emphasizing its scalability and adaptability. Indeed, the platform can be easily modified to detect other pathogens by changing the LAMP primers used in the assay, making it a versatile tool for monitoring a wide range of infectious diseases in both high- and low-resource settings.

“The sensor provides the advantages of low-cost materials and manufacturing processes, is easy to operate, and has low maintenance requirements – which is important when considering the situation in resource-poor regions (for example, lack of professionals and unstable power supply),” says Zhugen Yang, Professor of Biosensing and Environmental Health at Cranfield University, who led the development of the sentinel sensors. “The sensor is suitable for different user groups, such as health institutions, community organizations, as well as individuals.”

Commenting on the steps to widespread adoption for future pandemic preparedness, Yang says: “The technology must undergo rigorous testing and evaluation to ensure its accuracy, stability, and reliability under different conditions, providing a reliable basis for epidemic monitoring and prevention and control.” Yang also believes the technology needs to be automated and standardized – “so that functions can be expanded and upgraded according to actual needs.”

The Big Technical Challenges

With Zhugen Yang

What were the biggest technical challenges you faced in developing a sensor that is both cost-effective and sensitive enough to detect low viral loads in wastewater?

First, the sensor must have high sensitivity for the detection of ultra-low concentrations of viruses in wastewater. However, this often comes with specificity challenges also due to the impurities. Highly specific primers are essential to bind to the target sequence, enabling the distinction of the target virus from other similar pathogens and thereby enhancing sensitivity and specificity.

Second, the composition of wastewater is complex, with interfering factors such as organic matter, inorganic matter, and microorganisms that can severely impact the accuracy and stability of the sensor. Thus, optimizing the pretreatment of wastewater samples is essential to reduce non-specific adsorption and interference from other substances.

Third, environmental conditions (such as pH and salinity) in different wastewater collection areas can vary significantly. The sensor needs to maintain stable performance under diverse conditions to ensure accuracy and reliability.

Four, it is crucial to adopt low-cost materials and manufacturing processes and enable scale-up for mass production and consistency to achieve cost-effectiveness, enabling widespread deployment in resource-constrained regions.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Analytical science
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Could ≠ Should
Analytical science
Could ≠ Should

January 20, 2022

1 min read

The need to prevent the ordering of unnecessary tests

Diamonds Are a Diagnostician’s Best Friend
Analytical science
Diamonds Are a Diagnostician’s Best Friend

February 8, 2022

1 min read

A diagnostic sensor for rapid, cost-effective, and accurate detection of SARS-CoV-2

Hunting the Unknown
Analytical science
Hunting the Unknown

February 22, 2022

1 min read

When it comes to human health, we cannot ignore unknown molecules simply because they present analytical challenges

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.